HK1083220A1 - P53 binding polypeptide - Google Patents

P53 binding polypeptide

Info

Publication number
HK1083220A1
HK1083220A1 HK06101546.1A HK06101546A HK1083220A1 HK 1083220 A1 HK1083220 A1 HK 1083220A1 HK 06101546 A HK06101546 A HK 06101546A HK 1083220 A1 HK1083220 A1 HK 1083220A1
Authority
HK
Hong Kong
Prior art keywords
binding polypeptide
polypeptide
activity
inhibits
interfere
Prior art date
Application number
HK06101546.1A
Other languages
English (en)
Inventor
Xin Lu
Patricia Kuwabara
David Selwood
Original Assignee
Ludwig Inst Cancer Res
Genome Res Ltd
Ucl Cruciform Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0223193A external-priority patent/GB0223193D0/en
Priority claimed from GB0306261A external-priority patent/GB0306261D0/en
Application filed by Ludwig Inst Cancer Res, Genome Res Ltd, Ucl Cruciform Ltd filed Critical Ludwig Inst Cancer Res
Publication of HK1083220A1 publication Critical patent/HK1083220A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK06101546.1A 2002-10-07 2006-02-03 P53 binding polypeptide HK1083220A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0223193A GB0223193D0 (en) 2002-10-07 2002-10-07 Polypeptide
GB0306261A GB0306261D0 (en) 2003-03-19 2003-03-19 Polypeptide
PCT/GB2003/004296 WO2004031229A2 (en) 2002-10-07 2003-10-03 P53 binding polypeptide

Publications (1)

Publication Number Publication Date
HK1083220A1 true HK1083220A1 (en) 2006-06-30

Family

ID=32071253

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101546.1A HK1083220A1 (en) 2002-10-07 2006-02-03 P53 binding polypeptide

Country Status (9)

Country Link
US (2) US20060100143A1 (xx)
EP (2) EP1558638B1 (xx)
JP (1) JP2006517787A (xx)
AT (2) ATE425183T1 (xx)
AU (1) AU2003299132A1 (xx)
CA (1) CA2487206A1 (xx)
DE (1) DE60326623D1 (xx)
HK (1) HK1083220A1 (xx)
WO (1) WO2004031229A2 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0514538D0 (en) * 2005-07-14 2005-08-24 Ludwig Inst Cancer Res Variant polypeptide and screening assay
JP5649825B2 (ja) * 2007-01-31 2015-01-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 安定化させたｐ５３ペプチドおよびその使用法
KR101525754B1 (ko) 2007-03-28 2015-06-09 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
GB0716322D0 (en) * 2007-08-21 2007-10-03 Cancer Rec Tech Ltd Crystal structure
CN108570097A (zh) 2010-08-13 2018-09-25 爱勒让治疗公司 拟肽大环化合物
MX358886B (es) 2011-10-18 2018-08-31 Aileron Therapeutics Inc Macrociclos peptidomimeticos.
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
SG11201404648PA (en) 2012-02-15 2014-09-26 Aileron Therapeutics Inc Peptidomimetic macrocycles
EP2820041B1 (en) 2012-03-02 2017-06-14 Ludwig Institute For Cancer Research Ltd. Iaspp phosphorylation and metastatic potential
EP2914256B1 (en) 2012-11-01 2019-07-31 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
CN105636977A (zh) 2013-05-08 2016-06-01 加利福尼亚大学董事会 作为癌症治疗的新方法的p53聚集的基于结构的肽抑制剂
JP2017533889A (ja) 2014-09-24 2017-11-16 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその使用
CN112972378A (zh) 2014-09-24 2021-06-18 艾瑞朗医疗公司 拟肽大环化合物及其制剂
EP3294318A4 (en) 2015-03-20 2019-04-03 Aileron Therapeutics, Inc. PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1
WO2017059239A1 (en) * 2015-10-02 2017-04-06 Arizona Board Of Regents On Behalf Of Arizona State University Methods for processing biopolymeric arrays
US11091522B2 (en) 2018-07-23 2021-08-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2345497A1 (en) 1988-10-28 1990-04-28 Genentech, Inc. Growth hormone variants and method for forming growth hormone variants
JP2919890B2 (ja) 1988-11-11 1999-07-19 メディカル リサーチ カウンスル 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用
US6291158B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
EP0918874B1 (en) 1996-08-16 2001-03-07 Medical Research Council Self-replicating episomal expression vectors conferring tissue-specific gene expression
KR100272659B1 (ko) 1997-06-28 2000-12-01 김영환 반도체 소자의 금속배선 선폭 측정방법
CA2319089A1 (en) 1998-04-09 1999-10-21 Genset S.A. 5' ests and encoded human proteins
US6582933B1 (en) * 1998-12-03 2003-06-24 Ono Pharmaceutical Co., Ltd. Rel1A binding inhibitor, process for producing the same and utilization thereof
EP1159287A4 (en) 1999-03-12 2003-11-05 Human Genome Sciences Inc 50 HUMAN SECRETED PROTEINS
ES2277683T3 (es) * 1999-07-23 2007-07-16 Glaxo Group Limited Combinacion de anticuerpo anti-ep-cam con un agente quimioterapeutico.
US20040053262A1 (en) 2000-08-04 2004-03-18 Xin Lu Supressor gene

Also Published As

Publication number Publication date
CA2487206A1 (en) 2004-04-15
US7745571B2 (en) 2010-06-29
AU2003299132A1 (en) 2004-04-23
WO2004031229A3 (en) 2004-09-23
DE60326623D1 (de) 2009-04-23
ATE537186T1 (de) 2011-12-15
EP1947113A1 (en) 2008-07-23
EP1558638A2 (en) 2005-08-03
WO2004031229A2 (en) 2004-04-15
US20080260756A1 (en) 2008-10-23
EP1947113B1 (en) 2011-12-14
EP1558638B1 (en) 2009-03-11
ATE425183T1 (de) 2009-03-15
JP2006517787A (ja) 2006-08-03
US20060100143A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
HK1083220A1 (en) P53 binding polypeptide
IL161016A (en) Polypeptides capable of ang-2 binding
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
EP1700120A4 (en) MARKER FOR OPTICAL NEUROMYELITIS
MX2007001345A (es) Regiones variantes fc.
WO2004081026A3 (en) Polypeptides
GB0128898D0 (en) Materials and methods relating to the stabilization and activation of a tumour suppressor protein
WO2002065134A3 (en) Modulators of p53-p300 interactions and screening methods therefor
AU8497701A (en) Claudin polypeptides
EP1262556A3 (en) Antimicrobial peptides and method for identifying and using such peptides
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
AU2003288809A8 (en) Peptides that bind of the vegfr-2
WO2002093127A3 (en) Methods and reagents for identifying insulin response modulators and therapeutic uses therefor
WO2004016737A3 (en) Novel htnfsf13b protein variants
WO2003095484A3 (en) Polypeptides increasing p53 expression
WO2003099209A3 (en) Compositions and methods for screening and identifying anti-hcv agents
ATE537759T1 (de) Verbesserte zwinge
WO2002052274A3 (fr) Procede de criblage base sur les partenaires de liaison de tsap6
WO2003099783A3 (en) Tropane compounds
WO2006003427A8 (en) A protein involved in carcinoma
AU2002245984A1 (en) Screening assay for agents modulating activity of the abca1 protein
ZA200302057B (en) Erythrocyte binding protein.
AU2003290614A8 (en) Polypeptide having gnsaf activity and synthetic antibodies
ATE323289T1 (de) Auf tsap6-bindungspartnern beruhendes screeningverfahren
TW200635952A (en) Specific binding agents of human angiopoietin-2

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131003